Fenmotone is a trade name, mainly estradiol tablets estradiol dydrogesterone tablets composite package, belonging to the supplemental estrogen drugs. Drugs are not the best to say, only suitable or not, patients need to use the drug under the guidance of a professional doctor. The indications for this product are the symptoms of perimenopausal syndrome caused by natural and postoperative menopause, belonging to the compound preparation, mainly including estradiol and dydrogesterone, etc., which can be used to adjust the hormone level in the body, so as to achieve the purpose of treating the disease. Patients can take the medicine according to their own conditions and cooperate with their doctors, and then the dosage can be adjusted according to the clinical effects and depending on individual needs. Clinical trials and reported adverse reactions mainly include breast cancer, endometrial cancer, venous thromboembolism, and so on. The drug should be used with caution in patients with a known history of breast cancer or other dependent malignancies. It needs to be contraindicated for those who are allergic to the product’s color, and patients with high blood pressure, diabetes, liver disease, etc. need to use the drug under medical supervision. Nausea, vomiting, drowsiness and dizziness may occur in case of overdose of the drug.